Artwork
iconShare
 
Manage episode 316804503 series 2811616
Content provided by Patrick McCartney and INTERNATIONAL ESSENTIAL TREMOR FOUNDATION. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Patrick McCartney and INTERNATIONAL ESSENTIAL TREMOR FOUNDATION or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Jazz Pharmaceuticals is investigating a drug that acts to modulate the activity of t-type calcium channels associated with essential tremor. The investigational process and the work of Jazz is explained by staff members Michelle Baladi, senior director of global development, and Margaret Lee, head of neuroscience pharmacology.

  continue reading

35 episodes